Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Clinical trial NCT07256015 · RECRUITING
Trial details
- NCT number
- NCT07256015
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-08-05
- Primary completion
- 2027-07-05
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.